thiazolidinediones (TZDs)
Clinical Trials: ADOPT and CHICAGO
Two important studies on thiazolidinediones (TZDs), a class of insulin sensitizers, were published in November and December of 2006.
conference pearls
Around the world with your doctors to South Africa for the International Diabetes Federation conference and to Boston, to study weight management.
Dismantling Avandia, Actos and the TZDs
Dismantling Avandia, Actos and TZDs.
American Diabetes Association 68th Scientific Sessions – San Francisco (June 6-10)
When every fifth taxi in downtown San Francisco is carrying an ad for Byetta, FlexPen, or FreeStyle meters, you know the American Diabetes Association (ADA) is in town.
FDA Updates Warnings and Precautions Section of Actos Label after French and German Regulatory Authorities Suspend Drug Due to Possible Increased Risk of Bladder Cancer
Diabetes Care in the United States – An Interview with Noted Cardiologist Dr. Steven Nissen
Noted cardiologist, Dr. Nissen on Avandia.